Molt-X: BioWorks’ New Insecticide

Molt-X: BioWorks’ New Insecticide

Molt-X: BioWorks' New Insecticide

BioWorks has added a botanical insecticide, Molt-X, to its product line.


Molt-X was recently EPA approved and it has multiple modes of action to provide broad-spectrum control over pests like aphids, whiteflies, thrips, mealybugs, scales, plant-parasitic nematodes and others.
Molt-X works primarily as an insect growth regulator that disrupts the molting process in insects. Once treated with Molt-X, insects become sluggish, stop feeding and fail to mature and reproduce. Molt-X also acts as an insect repellent, antifeedant and ovipositional deterrent. These multiple modes of action make it a highly effective tool for use in a resistance management program.
Other key features of Molt-X are it:

–Leaves no residue on plant foliage and flowers
–Has no phytotoxicity issues on most plants
–Is generally safe on beneficial insects and bees; and
–Is compatible for tank-mixing/rotation with other registered inputs, including BotaniGard and SuffOil-X. 

“This is an excellent compliment to our existing products,” says John Francis, BioWorks director of technical services. “Molt-X has been tested and shown to be an effective tank-mix and rotational partner with both BotaniGard and SuffOil-X. By using the combinations in a pest management program, you can control resistant insects and reduce the likelihood of resistance development.”
Molt-X is an emulsifiable concentrate containing 3 percent azadirachtin–the most potent of the insect-active compounds found in the neem tree. While it is derived from neem seed, Molt-X is not a neem oil. It has a four-hour restricted entry intervaala, zero-day pre-harvest interval and is labeled for use on a broad range of turfgrass, outdoor shrubs, trees, ornamentals and food crops, as well as on greenhouse ornamentals and shadehouse, interiorscape and nursery crops.

BioWorks will offer Molt-X in both quarts and pint sizes in approved states beginning March 1.

For more information on BioWorks and Molt-X, visit